Skip to main content

Study M544

Study name

Hu ZC 2019

Title

Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics

Overall design

In this study, a proton nuclear magnetic resonance (H NMR)-based metabonomic approach was employed to profile plasma samples from 32 post-stroke depression (PSD group), 35 stroke patients (stroke group) and 35 healthy comparison subjects (control group) in order to identify metabolite biomarkers for PSD (the training set). Then, 10 PSD, 11 stroke patients and 11 healthy comparison subjects (test set) were used to validate the diagnostic performance of these biomarkers.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Post-stroke depression; Post-stroke depression;

Criteria for depression

DSM-5 diagnosed major depression and minor depression, HAMD-17 > 8

Sample size

134

Tissue

Peripheral; Blood; Plasma;

Platform

NMR; NMR: Bruker Avance 600 spectrometer;

PMID

31118636

DOI

10.2147/NDT.S192307

Citation

Hu Z, Fan S, Liu M, et al. Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics. Neuropsychiatr Dis Treat. 2019;15:867-881.

Metabolite

L-Phenylalanine;

L-Tyrosine;

1-Methylhistidine;

3-Methylhistidine;

LDL CH3-(CH2)n;